KZIA
Kazia TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
Current thesis
Primary-source evidence supports a cautious upside case built around several real 2026 shots on goal: Q2 FDA path-forward feedback in GBM, 2H neuro-oncology readouts, and 2H breast-cancer efficacy/biomarker updates. March 2026 materials also cited roughly US$46 million of cash, no debt, and runway into 2029 excluding additional or expanded trials, which helps support continued execution [#IR-2026-03-27].
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -11.7.
What can break
Clinical evidence remains early and fragile, with the January 2026 TNBC update based on a very small number of patients and no mature randomized efficacy readout yet.
Momentum
78
Value
41
Sentiment
31
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $12.00 · Bull $19.00 · Bear $5.50
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-28 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-21
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $27.80
Why
Momentum78 · Δ7d -11.7
Value41 · Δ7d +0.1
Sentiment31 · Δ7d -1.9
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
78
26% active weight
Current posture
7d trendSoftening
Δ7d
-11.7
Δ21d
-6.8
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.0
Sentiment
31
34% active weight
Current posture
7d trendSoftening
Δ7d
-1.9
Δ21d
+2.0
Why this grade
Composite grade D. Momentum 78.4 / Value 41.1 / Sentiment 30.7
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$153.6M
Beta
1.79
Shares Out
11.34M
P/E (TTM) · Derived
-3.7
P/S (TTM)
802.17
P/FCF (TTM) · Derived
-2.26
Rev YoY
-96.3%
EPS YoY
+96.8%
Gross Margin
-
Op Margin
-21258.8%
Net Debt
-$2.59M
Current Ratio
2.87
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology